For a heart just damaged by a blocked artery, timing matters. So does access. That is what makes a new experimental treatment ...

Proper pullet vaccination underpins the protection of layers and broiler breeders during the rearing phase. When done correctly, it stabilises egg ...

AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3, randomized, placebo-controlled, double-blind AFFIRM study evaluating the efficacy and safety of risankizumab (SKYRIZI®) ...

Compounded NAD+ Telehealth Access, FDA Classification, Pharmacy Sourcing Standards, Prescription Requirements, and Consumer ...

Local lidocaine injection shows a similar early anesthetic effect in adults with Ehlers-Danlos syndrome and healthy ...

Roche Group AG’s RHHBY obesity drug push faces stiff competition after Genentech, a unit of Roche, reported Phase 2 results showing up to 10.7% weight loss—below expectations and lagging leading ...

The Karnataka government has launched the 'Kusuma Sanjeevini' scheme, targeting haemophilia patients. It aims to prevent bleeding episodes rather than treat them, utilizing modern preventive therapy.

Subcutaneous (SC) amivantamab reduces administration from hours to minutes, with efficacy and safety consistent with intravenous (IV) amivantamab1,2,3,4,5 SC amivantamab is now authorised across all ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Ascendis Pharma’s Yuviwel (navepegritide) for ...

A new study finds that GLP-1 drugs may help to stabilize chronic migraines, with patients seeing fewer ER visits and less ...

Halozyme Therapeutics has expanded its portfolio of drug delivery technologies for a second time in a few months with the acquisition of Surf Bio and its subcutaneous injection platform. The ...

Johnson & Johnson's (JNJ) stock is in focus as the FDA approves a multiple myeloma therapy developed by the company with Halozyme (HALO). Read more here.